10 01, 2021 Alberto Pavan et al., Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome adlitterio663392022-10-13T16:35:11+02:00 Leggi di più
25 05, 2020 Alberto Pavan et. al., Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome. Diatech Pharmacogenetics2020-11-03T15:06:19+01:00 Leggi di più
